Heghine Khachatryan: New Evidence in Perioperative Hemostasis – Clinical Value of Perioperative TXA Use in General Surgery
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post by JAMA Surgery on LinkedIn:
“New Evidence in Perioperative Hemostasis
A newly published systematic review and meta-analysis in JAMA Surgery highlights the clinical value of perioperative tranexamic acid (TXA) use in general surgery.
Key findings:
- Significant reduction in intraoperative blood loss
- Decreased transfusion requirements
- Lower incidence of major bleeding
- No observed increase in thromboembolic events
These data further support TXA as an effective and safe component of modern blood management strategies when used appropriately and with proper patient selection.
For hematologists, surgeons, anesthesiologists, and perioperative teams, this reinforces the importance of evidence-based antifibrinolytic use as part of multidisciplinary bleeding control and patient blood management (PBM) programs.
Perioperative Use of Tranexamic Acid in General Surgery: A Systematic Review and Meta-Analysis
Published online: December 17, 2025 | JAMA Surgery
A meaningful step toward safer surgery, fewer transfusions, and better outcomes.”
Quoting JAMA Surgery’s post:
“Systematic review and meta-analysis: Prophylactic TXA use was associated with lower intraoperative blood loss, transfusion requirements, and major bleeding without an observed increase in thromboembolic or mortality risk.”
Title: Perioperative Use of Tranexamic Acid in General Surgery: A Systematic Review and Meta-Analysis
Authors: Lucas Monteiro Delgado, Bernardo Fontel Pompeu, Gabriel Henrique Acedo Martins, Mariana Lima Azevedo, Eric Pasqualotto, Thiago Celestino Chulam, Sérgio Mazzola Poli de Figueiredo
Read the full article here.
Stay updated and find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Apr 15, 2026, 21:27Satish Bondala: Blood Bank and Transfusion Services – The Lifeline of Hospitals
-
Apr 15, 2026, 21:26Tareq Abadl: Understanding Thalassemia – Breaking the ‘Ordinary Anemia’ Myth
-
Apr 15, 2026, 21:24Wolfgang Miesbach: Key Message from John Semple on Platelets as Immune Cells in ITP
-
Apr 15, 2026, 21:22Manuel Gutiérrez de Ravé: Promotion to Real-World Evidence Scientist at Terumo Blood and Cell Technologies
-
Apr 15, 2026, 18:45Elias Lee: Acute PE from Subclavian VT – CT Scan Diagnosis, Radiology Interpretation, and Emergency Imaging Insights
-
Apr 15, 2026, 17:30Rivaroxaban versus Aspirin after Atrial Fibrillation Ablation – Cardiology Insights and Heart Health
-
Apr 15, 2026, 17:01Emmanuel J Favaloro: A Practical Approach to Inherited and Acquired Coagulation Disorders
-
Apr 15, 2026, 16:55Chokri Ben Lamine: VA-ECMO vs VV-ECMO Thromboembolic Events – Key Clinical Pearls
-
Apr 15, 2026, 16:54Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory